Michael Kishbauch

2009

In 2009, Michael Kishbauch earned a total compensation of $906K as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 52% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$188,875
Option Awards$333,700
Salary$377,750
Other$5,626
Total$905,951

Kishbauch received $377.8K in salary, accounting for 42% of the total pay in 2009.

Kishbauch also received $188.9K in non-equity incentive plan, $333.7K in option awards and $5.6K in other compensation.

Rankings

In 2009, Michael Kishbauch's compensation ranked 4,787th out of 9,885 executives tracked by ExecPay. In other words, Kishbauch earned more than 51.6% of executives.

ClassificationRankingPercentile
All
4,787
out of 9,885
52nd
Division
Manufacturing
1,712
out of 3,690
54th
Major group
Chemicals And Allied Products
345
out of 866
60th
Industry group
Drugs
213
out of 638
67th
Industry
Pharmaceutical Preparations
163
out of 446
64th
Source: SEC filing on April 16, 2012.

Kishbauch's colleagues

We found five more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2009.

2009

Milind Deshpande

Achillion Pharmaceuticals

Chief Scientific Officer

2009

Joseph Truitt

Achillion Pharmaceuticals

Senior Vice President and Chief Commercial Officer

2009

Gautam Shah

Achillion Pharmaceuticals

Senior Vice President and Chief Compliance Officer

2009

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2009

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

You may also like